Neusoft Medical System’s PET Obtains U.S. FDA Authentication
This article was originally published in PharmAsia News
Executive Summary
Neusoft Medical System, a subsidiary of Neusoft Group, has received the go-ahead from U.S. FDA to market its positron emission computer tomography technology in the U.S. It represents China's first corporation capable of producing PET technology and marketing it globally. At present, China spends hundreds of million dollars each year importing medical equipment. About 70 percent of the local high-end medical device market is monopolized by MNCs; for instance, GE, Siemens and Philips have cornered the CT and MR sector. Neusoft Medical System's PET technology not only fills a gap in the country's high-end medical equipment manufacturing, but also marks a milestone in reforming the trade structure of the healthcare industry. The company will sell its first machine to the U.S. this July. (Click here for more - Chinese Language)